Mometazonfuroat Cipla 50 mikrograma po potisku sprej za nos, suspenzija
| Name | Mometazonfuroat Cipla 50 mikrograma po potisku sprej za nos, suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-200034872 |
| Active Substance | mometazonfuroat hidrat |
| Composition | svaki potisak oslobađa 50 mikrograma mometazonfuroata (u obliku hidrata) kao isporučenu dozu (po potisku) |
| Pharmaceutical Form | sprej za nos, suspenzija |
| Manufacturer | S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka Orion Corporation, Orion Pharma, Espoo, Finska Orion Corporation, Orion Pharma, Salo, Finska Cipla Europe NV, Antwerpen, Belgija |
| Marketing Authorisation Holder | Cipla Europe NV, De Keyserlei 60C, Bus 1301, Antwerpen, Belgija |
| Marketing Authorisation Date | 05.07.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/227 |
| Registration Number | 381-12-01/70-19-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R01AD09 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
